We imagine a healthcare system where each patient’s journey is deeply informed by their whole-person context, including genomic, clinical, social, and protective risk factors.
2023 marked a pivotal moment, as we transitioned from developing our genomics program infrastructure to launching multiple early detection and precision therapy programs.
Read the reportWe believe healthcare should be personalized to each individual's needs and context, including the clinical, genomic, and social factors that contribute to shaping health outcomes. We work to ensure that genomic information is accessible and actionable for all patients and caregivers, and then we use our science engine to weave whole-person precision medicine into the very fabric of our care delivery.
Working across the continuum of prevention to treatment, and therapies, we turn today's most promising innovations into tomorrow's standard of care.
“Genomics has fundamentally transformed the clinical care of our oncology patients and is at the core of the innovations that will drive the future of personalized medicine.”
- Carlo Bifulco, MD
CMO, Providence Genomics and Associate Member, Translational Molecular Pathology, Earle A. Chiles Research Institute
"Precision prevention begins with knowing your risk. Besides the tremendous advances in identifying cancer risk and targeted treatment, the genome can provide insight into treating everything from depression to high cholesterol."
- Ora Karp Gordon, MD, MS, FACMG
Clinical Director, Providence Population Genomics Program, and Regional Director Southern California, Clinical Genetics and Genomics
"Our team has produced an AI tool that accurately and automatically diagnoses cancer and predicts genomic alterations. Future models will integrate data from many sources, assess real-time cancer risk and suggest personalized options for early diagnosis, treatment and/or risk management."
- R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed), Executive Medical Director, Providence Cancer Institute
